[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 4 sources · 4 days · First seen · Last updated

Public health impacts of shingles and chickenpox vaccines

Overview

Research indicates various public health benefits associated with varicella zoster virus vaccinations. In the United States, data from Epic Research suggests that widespread chickenpox vaccination has led to a decline in shingles rates among younger adults. For individuals aged 25 to 29, shingles rates reportedly dropped from approximately 7.5 to 7.7 per 10,000 people in 2019 to roughly 3.0 to 3.2 per 10,000 in 2026.

Separately, a study published in ‘Hypertension Research’ involving patients in Taiwan found a correlation between the recombinant shingles vaccine and improved outcomes for those with chronic kidney disease. The study of over 26,000 adults suggested that vaccinated individuals had a 49% reduction in all-cause mortality and lower risks of kidney-related and cardiovascular events compared to unvaccinated individuals. Medical experts noted that while these correlations are significant, the vaccine is intended for shingles prevention rather than as a treatment for kidney or cardiovascular diseases.

Entities

National Taiwan University Hospital · Kersten Bartelt · United States · Lohas Hospital · Centers for Disease Control, Taiwan

Timeline

  1. [HEALTH] 2 sources
    Shingles vaccine linked to lower mortality in kidney disease patients

    A study published in ‘Hypertension Research’ suggests the recombinant shingles vaccine is associated with lower risks of kidney events, cardiovascular disease, and mortality in chronic kidney disease patients.

  2. [HEALTH] 2 sources
    Chickenpox vaccine linked to declining shingles rates in young adults

    A study of 85 million US patients suggests chickenpox vaccinations are driving a significant decline in shingles cases among adults aged 34 and younger.

Sources

health.ettoday.net · mnnofa.com · nbcnews.com · twcn.com.tw